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Abstract
Background: Nuclear localization of cyclin B1 is an indicator for cells undergoing mitotic division, and the over-
expression has shown promising results as a good prognostic predictor for patients of squamous cell carcinoma 
(SCC). Cyclin B1 overexpression among histological grades of conventional oral squamous cell carcinoma (CO-
SCC), as well as comparison with verrucous carcinoma (VC) has been less investigated.
Study Design: Immunohistochemical expression of cyclin B1 was compared with various clinicopathological 
features in 30 primary COSCC and 31 primary VC cases.
Result: Cyclin B1 showed significant overexpression for some clinical features for both the variants of oral sq-
uamous cell carcinoma. In histopathological variants, statistical significance was observed among grades of CO-
SCC, as well as COSCC and its grades with VC. The concomitant increase in cyclin B1 overexpression from VC 
to grades COSCC was observed.
Conclusion: Our study findings draw attention to cyclin B1 overexpression is involved in early carcinogenesis, cell 
differentiation and tumor proliferation. 
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Introduction
Dysregulation of the cell cycle machinery is a funda-
mental hallmark of cancer progression and the cell pro-
grammers of proliferation, differentiation, senescence 
and apoptosis are intimately linked to the cell cycle 
regulatory machinery (1-3). Cyclin B1 is a key factor for 
G2-M phase transition as well as cyclin B1/Cdk complex 
pushes cell from G2 phase to M phase and hence this is 
well-known as maturation promoting factor (MPF) (4).
 This complex performs chromatin condensation, nu-
clear envelope breakdown, fragmentation of golgi ap-
paratus and endoplasmic reticulum as well as spindle 
formation by microtubule instability. Subsequently at 
prophase and at beginning of anaphase an ubiquitin 
ligase (E3) known as the anaphase-promoting complex/
cyclosome (APC/C) will get attached to cyclin B1 and 
Cdk complex which triggers the destruction of the mi-
totic cyclins (5).
The conventional tumor and several histological sub-
types of squamous cell carcinoma present axiomatic 
morphologic features and behavior; this can be associat-
ed with differences in prognosis when they occur in the 
oral mucosa (6,7). Verrucous carcinoma is an distinct 
variant of squamous cell carcinoma, clinically charac-
terized by an exophytic, warty, slow growing neoplasm 
with histologicaly as an extremely well-differentiated 
squamous cell carcinoma with pushing margins and 
non-metastasizing (6,8).
The present study is planned to explore the importance 
of nuclear expression of cyclin B1 in metastasizing con-
ventional SCC, that is well differentiated squamous cell 
carcinoma (WDSCC), moderately differentiated squa-
mous cell carcinoma (MDSCC) and poorly differenti-
ated squamous cell carcinoma (PDSCC) which have not 
been well-studied and also to study and compare with 
non-metastasizing variants of oral squamous cell car-
cinoma that is verrucous carcinoma. Furthermore, the 
present study also refers to the biological behavior of 
tumor from the standpoint of the difference in staining 
pattern and overexpression of cyclin B1 in different his-
tological grades of COSCC versus VC.
Methodology
In this retrospective, cross-sectional study, randomly 
selected 30 cases of primary COSCC and 31 cases of 
primary VC were selected. Patients, who did not receive 
any kind of preoperative therapy, underwent radicular 
neck dissection as part of treatment and recurrence free 
for three year follow-up were included. 50 men and 11 
women (median age 51 years) suffering from primary 
oral squamous cell carcinoma were selected as per 
pTNM stages I-III as per American join committee on 
cancer guidelines. Due to small sample size and for 
clinical convenience lesion present on palate or alveolar 
ridge and gingiva are categorized as lesions on bound 
down mucosa and loose mucosa when lesions were 
present on buccal mucosa or tongue. 
Two pathologists decided the tumor grade and type ac-
cording to the histological classification of oral cancer 
by the World health organization-histological malig-
nancy grading. Histological subtypes included 30 cases 
of conventional oral squamous cell carcinoma, among 
which 11 were WDSCC, 10 MDSCC and 9 PDSCC. 
There were 31 cases of VC. Normal mucosa of five pa-
tients was taken as control.
-Immunohistochemistry:
Paraffin-embedded tissue sections at 4 micron thick 
of two to three serial sections from all 61 tumors were 
taken on silinated slides (Sigma Aldrich Comp. USA). 
All the slides were then deparaffinized through a series 
of xylene baths and were rehydrated in graded alcohols. 
Then sections were heated in a pressure cooker in 10 
mM citrate buffer (pH 6.0) for 8 minutes for antigen re-
trieval followed by incubating in 0.3% hydrogen perox-
ide for 20 min to block endogenous peroxides activity. 
Later sections were incubated with primary anti– cyc-
lin B1 monoclonal antibody (monoclonal, clone V152; 
Dako Corp, Denmark) diluted to the ration of 1:200 in 
tris buffered solution antibody diluent solution and in-
cubated at room temperature for overnight in a humidi-
fying chamber. After further incubations with second-
ary Antibody (45 minutes) and streptavidin peroxidase 
(30 minutes), visualization was performed using freshly 
prepared DAB (di-amino-benzidine) chromogen for 
10 minutes. The slides were then counterstained with 
the Harris hematoxylin stain. Normal epithelium was 
served as positive control, and negative control was 
checked by omitting primary antibody.
All slides were analyzed by two investigators who were 
unaware of clinical information. The cyclin B1 labeling 
index was defined as the percentage of tumor cells dis-
playing nuclear immunoreactivity among 1000 tumor 
cells, and it was calculated by counting the number of 
cyclin B1-stained tumor cells from appropriate areas of 
each tissue section. Tumors showing ≥ 5% tumor cells 
showing nuclear expression are considered for cyclin B1 
overexpression. SPSS version 17 software was used for 
statistical analysis and a p value less than 0.05 consid-
ered for significance with a confidence of 95%.
Results
Cyclin B1 was expressed to some extent in all normal 
and cancer tissues, localized either in cytoplasm or nu-
cleus. The WDSCC (Fig. 1) showed nuclear staining of 
cyclin B1 in peripheral layers of cells, in tumor islands 
as well as in sheets. However there were scattered areas 
of nuclear staining cells in MDSCC, whereas PDSCC 
(Fig. 2) showed predominant nuclear staining for cyclin 
B1. The VC (Fig. 3) has showed more uniform stain-
ing, with nuclear positive cells in basal as well as para-
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basal areas and superficial layer showed predominant 
cytoplasm staining. The dysplastic areas adjoining or 
overlying the lesion has showed staining with varying 
degree and served as internal control.
The cyclin B1 overexpression was compared for differ-
ent clinical parameters for COSCC and VC (Table 1). 
ANOVA and Mann Whitney U-test were used to assess 
the strength of association between the categories of 
COSCC, and VC (Table 2).
Discussion
The cell cycle markers are some of the most powerful 
predictors of survival for cancer patients (9-13). Most of 
the studies have focused on G1-S transition, but there 
are very few published research papers on G2-M transi-
tion using cyclin B1 among these two variants of oral 
carcinoma. Nuclear localization of cyclin B1 overex-
pression is associated with poor outcome in carcinoma 
of oral cavity (3,7,14,15), esophagus (10,12), breast (13), 
lung (16,17) and colorectal cancer (18).
In the present study, we observed that the cyclin B1 is 
localized either in nucleus or in cytoplasm, and was 
consistent with others observations (7,13,14). In breast 
cancer cytoplasmic expression of cyclin B1 protein was 
recognized in the nonmitotic phase, and nuclear expres-
sion in the mitotic phase (19). Nozoe et al. (3) concluded 
that the nuclear expression showed better prognostic 
prediction in esophageal squamous cell carcinoma than 
the cytoplasmic expression. Cyclin B1 was observed in 
1% to 80% cells of colorectal cancer (18), Takeno et al. 
(9) in SCC of esophagus showed that no statistical sig-
nificant difference existed in prognosis at 5% to 20% 
cutoffs value for overexpression.
The clinical parameters age and gender in COSCC and 
VC is comparable with oral carcinoma (20), and esopha-
geal SCC (10) and in colorectal carcinoma (18). Has-
san et al. (14) in SCC of tongue and Nozoe et al. (3) 
in esophageal SCC found contrasting results. This may 
be due to the difference in consideration of nuclear or 
cytoplasmic expression as positive for cyclin B1 overex-
pression. Similarly, for location of tumor the cyclin B1 
overexpression in loose bound mucosa is rapidly prolif-
erating in VC than COSCC when compared to bound 
down mucosa and this is in concurrence with various 
other sites like tongue (13-15) and esophagus carcinoma 
(3). Early invasion and local aggressiveness of tumor is 
limited by anatomical structures in VC than COSCC, 
contrast to this overall expression among both variants 
is insignificant. Tobacco habit in VC has shown very 
significant results, indicating tobacco has many more 
roles in VC initiation and local aggressiveness. The 
statistical insignificant correlation of overexpression in 
COSCC over VC is observed, this can be due to differ-
ent biological role in genders and two age groups for dif-
ferent histological variants, than overall oral squamous 
cell carcinoma. This may perhaps be the change in the 
trend of occurrence of oral, head and neck cancer for 
age and gender as it noticed in younger patients (4%-6% 
increase) and two fold increase in females (21,22). As 
there is no available study in the literature, hence com-
parison could not be made. However it appears to be the 
Fig. 1. Nuclear positive cyclin B1 cells in peripheral of islands in well 
differentiated squamous cell carcinoma (400x).
Fig. 2. Predominant Nuclear positive cyclin B1 cells in poorly dif-
ferentiated squamous cell carcinoma (400x).
Fig. 3. Nuclear positive cells located in basal and suprabasal cells 
(100x), inset showing areas of dysplastic cells in verrucous carci-
noma (400x).
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development of carcinoma and its biological aggressive 
behavior is a multifactorial such as genetic susceptibil-
ity, immunological predisposition (22) allelic loss of 
heterozygocity (21,22). When COSCC is compared with 
VC, later is more common in male and also associated 
with tobacco habit (6,8). VC particularly associated with 
human papilloma virus (22) and its biological behavior 
is between SCC and verrucous hyperplasia (6,8) also 
VC has intrinsic potential for local recurrence (6). 
The lymph node metastasis in COSCC is in contrast 
Parameters Total Positive Negative p Total Positive Negative Negative p
 30 25(83%) 5 (17%)  31 14 (45%) 17 (55%)  0.0065,S 
Age          
< 50 15 12 (80%) 3 (20%) 0.0001,S 17 3 (18%) 14 (82%) 0.0001,S 0.866,NS 
> 50 15 13 (87%) 2 (13%)  14 11 (79%) 3 (21%)   
Gender          
Male  27 23 (85%) 4 (15%) 0.004,S 23 10 (43%) 13 (57%) 0.0001,S 0.907,NS 
Female  3 2 (67%) 1 (33%)  8 4 (50%) 4 (50%)   
Tobacco habit          
No 6 5 (83%) 1 (17%) 0.741,NS 4 1 (25%) 3 (75%) 0.0001,S 0.0001,S 
Yes 24 20 (83%) 4 (17%)  27 13 (48%) 14 (52%)   
Location          
Bound down mucosa 13 9 (69%) 4 (31%) 0.07,NS 9 0 (0%) 9 (100%) 0.006,S 0.429,NS 
Loose mucosa 17 16 (94%) 1 (6%)  22 14 (64%) 8 (36%)   
Nodal status          
N0 5 5 (100%) 0 (100%) 0.002,S     NA 
N1-N3  25 20 (80%) 5 (20%)       
      COSCC         VC COSCC vs VC
Table 1. Cyclin B1 status and comparison in both variants of oral squamous cell carcinoma tumors according to clinical parameters. 
COSCC: conventional oral squamous cell carcinoma; VC: verrucous carcinoma; NA: not applicable; S: significant; NS: not significant.
Groups Total Positive Negative Mean ± SD p
WDSCC* 11 9 (82%) 2 (18%) 6.60 ± 1.24 0.0001,S 
MDSCC 10 7 (70%) 3 (30%) 7.42 ± 1.74  
PDSCC 9 9 (100%) 0 (0%) 10.15 ± 1.46  
WDSCC# 11 9 (82%) 2 (18%) 6.60 ± 1.24 0.351,NS 
MDSCC 10 7 (70%) 3 (30%) 7.42 ± 1.74  
WDSCC# 11 9 (82%) 2 (18%) 6.60 ± 1.24 0.0001,S 
PDSCC 9 9 (100%) 0 (0%) 10.15 ± 1.46  
MDSCC# 10 7 (70%) 3 (30%) 7.42 ± 1.74 0.0048,S 
PDSCC 9 9 (100%) 0 (0%) 10.15 ± 1.46  
COSCC# 30 25 (83%) 5 (17%) 8.10 ±2.13 0.0065,S 
VC 31 14 (45%) 17 (55%) 6.21 ± 1.16  
WDSCC# 11 9 (82%) 2 (18%) 6.60 ± 1.24 0.6542,NS 
VC 31 14 (45%) 17 (55%) 6.21 ± 1.16  
MDSCC# 10 7 (70%) 3 (30%) 6.60 ± 1.24 0.0641,NS 
VC 31 14 (45%) 17 (55%) 6.21 ± 1.16  
PDSCC# 9 9 (100%) 0 (0%) 10.15 ± 1.46 0.0001,S 
VC 31 14 (45%) 17 (55%) 6.21 ± 1.16  
Table 2. Cyclin B1 overexpression in subgroups of COSCC and VC.
*Comparison of between group and within group is made by ANOVA method.
# Pair wise among groups is done by comparison by Mann Whitney U-test.
WDSCC: well differentiated squamous cell carcinoma; MDSCC: moderately differentiated squamous cell 
carcinoma; PDSCC: poorly differentiated squamous cell carcinoma; VC: verrucous carcinoma; S: signifi-
cant; NS: not significant.
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to studies in tongue (14), lung cancer  (17,18) and es-
ophageal squamous cell carcinoma (3) but comparable 
with Takeno et al. (9) who observed significant differ-
ence among clinical configuration and location of tumor 
against nodal status in esophageal cancer. Yoshida et al. 
(16) found vascular invasion of tumor cell correlate with 
over expression of cyclin B1 in non-small-cell lung can-
cer and Grabsch et al. (18) found no significance of cyc-
lin B1 overexpression in colorectal cancer. The present 
study showed cyclin B1 is not independent of clinical 
parameters of COSCC and VC.
Our observation of cyclin B1 overexpression among 
grades of COSCC are comparable with Kushner et al. 
(7) report and increasing grades of dysplasia in es-
ophagus (3,12). Hassan et al. (14) observed a trend of 
association of cyclin B1 and epithelial differentiation. 
However, correlation of cyclin B1 overexpression and 
lack of differentiation was observed in COSCC and his-
tological grades by Kushner et al. (7) and Geddert et al. 
(12) for metaplastic, dysplastic and carcinoma sequence 
in Barett’s esophagus. The association between differ-
ent grades of COSCC showed significant results. There 
appears to be cyclin B1 tend to move form cytoplasm 
to nucleus with grades of COSCC thus increasing the 
mitotic index in higher grades.
The present study showed an overlap of cyclin B1 per-
centage overexpression in grades of COSCC. This in-
dicates perpetuation of cellular differentiation and may 
also influence the localization of cyclin B1. Our results 
of comparison of PDSCC, with WDSCC and MDSCC 
are consistent to Yoshida et al. (16) results. No statisti-
cal significant difference among WDSCC and MDSCC 
was observed, this concomitant inconsistency precludes 
use of cyclin B1 expression as an indicator for grading 
in contrast to Watanabe et al. (23) observation. This 
could be because cyclin B1 is exported to nucleus ahead 
of schedule by overriding nuclear export versus nuclear 
import, or there may be abnormal entry or exit from cell 
cycle than primary within cell cycle as reported by Lao-
Sirieix et al. (19). This study also supports the findings 
of Nozoe et al. (3) that the poorly differentiated tumor 
has large number of cells undergoing repeated rounds 
of cell cycle.
Importantly the VC, a locally invasive tumor, showed a 
statistically significant decreased cyclin B1 overexpres-
sion, as compared with COSCC similar to de Spíndu-
la-Filho et al. (22) study. Thus cells undergoing active 
mitosis and differentiation in both the carcinoma may 
be of different mechanism. Cyclin B1 overexpression is 
observed in basal and parabasal layers of VC and pe-
ripheral layers of islands of WDSCC, compared to in-
vasive tumor front of oral squamous cell carcinoma by 
Watanabe et al. (23) and esophageal carcinoma by Song 
et al. (10) Interestingly, VC had not showed any statisti-
cal significant difference with WDSCC and MDSCC. 
There must be more biological significance of cyclin 
B1 than just proliferation in squamous cell carcinoma 
(3,10,11,22,24). The present study showed that the cells 
in carcinoma with aberrant nuclear localization of cyc-
lin B1 not only pushes on cell from G2-M mitosis phase 
but also demonstrate lack of cell differentiation into 
next stratum.
Conclusion
Our study findings draw attention to cyclin B1 over-
expressions involvement in early carcinogenesis, cell 
differentiation and tumor proliferation. Clinicopatho-
logical factors have certain influence on overexpression 
of cyclin B1 in both the variants of SCC, as cyclin B1 
localization tends to move about from cytoplasm to nu-
cleus with lack of cell differentiation in COSCC. How-
ever overlap of nuclear overexpression among grades 
precludes use of cyclin B1 over expression as an indica-
tor for grading and also cyclin B1 is not a good indicator 
to assess the variants of oral squamous cell carcinoma.
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